Clinical trial
A Phase 1B Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects
NCT07717918 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1B Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 6, 2026
- Completion date
- August 5, 2026
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy